5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-4-[[(3R)-piperidin-3-yl]amino]-1H-pyrimidin-6-one;tert-butyl (3R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-6-oxo-1H-pyrimidin-4-yl]amino]piperidine-1-carboxylate
C49H64N12O4S2 — CID 158318379
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-4-[[(3R)-piperidin-3-yl]amino]-1H-pyrimidin-6-one;tert-butyl (3R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-6-oxo-1H-pyrimidin-4-yl]amino]piperidine-1-carboxylate
5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-4-[[(3R)-piperidin-3-yl]amino]-1H-pyrimidin-6-one;tert-butyl (3R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-6-oxo-1H-pyrimidin-4-yl]amino]piperidine-1-carboxylate (PubChem CID 158318379) has the molecular formula C49H64N12O4S2 and a molecular weight of 949.26 g/mol. Its IUPAC name is 5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-4-[[(3R)-piperidin-3-yl]amino]-1H-pyrimidin-6-one;tert-butyl (3R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-6-oxo-1H-pyrimidin-4-yl]amino]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | 5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-4-[[(3R)-piperidin-3-yl]amino]-1H-pyrimidin-6-one;tert-butyl (3R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-6-oxo-1H-pyrimidin-4-yl]amino]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 158318379 |
| Molecular Formula | C49H64N12O4S2 |
| Molecular Weight | 949.26 g/mol |
| Exact Mass | 948.46 |
| IUPAC Name | 5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-4-[[(3R)-piperidin-3-yl]amino]-1H-pyrimidin-6-one;tert-butyl (3R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(1-methylpiperidin-4-yl)-6-oxo-1H-pyrimidin-4-yl]amino]piperidine-1-carboxylate |
| SMILES | CN1CCC(c2nc(N[C@@H]3CCCN(C(=O)OC(C)(C)C)C3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1.CN1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1 |
| InChI | InChI=1S/C27H36N6O3S.C22H28N6OS/c1-27(2,3)36-26(35)33-13-7-8-18(16-33)28-23-21(25-29-19-9-5-6-10-20(19)37-25)24(34)31-22(30-23)17-11-14-32(4)15-12-17;1-28-11-8-14(9-12-28)19-26-20(24-15-5-4-10-23-13-15)18(21(29)27-19)22-25-16-6-2-3-7-17(16)30-22/h5-6,9-10,17-18H,7-8,11-16H2,1-4H3,(H2,28,30,31,34);2-3,6-7,14-15,23H,4-5,8-13H2,1H3,(H2,24,26,27,29)/t18-;15-/m11/s1 |
| InChIKey | GONTXHKZBWOBKU-GNPGSHRGSA-N |
| XLogP | 7.69 |
| TPSA | 189.39 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 67 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 949.26 |
| LogP ≤ 5 | 7.69 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158318379 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.